Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis

Bone Marrow Transplantation volume 51, pages 1050–1061 (2016)Cite this article

Subjects

Abstract

The outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients has significantly improved over the past decade. Still, a significant number of patients require intensive care unit (ICU) management because of life-threatening complications. Literature from the 1990s reported extremely poor prognosis for critically ill allo-HSCT patients requiring ICU management. Recent data justify the use of ICU resources in hematologic patients. Yet, allo-HSCT remains an independent variable associated with mortality. However, outcomes in allo-HSCT patients have improved over time and many classic determinants of mortality have become irrelevant. The main actual prognostic factors are the need for mechanical ventilation, the presence of GvHD and the number of organ failures at ICU admission. Recently, the development of reduced-intensity conditioning regimens, early ICU admission and the increased use of noninvasive ventilation, combined with time effect and general advances in hematology, in allo-HSCT procedures and in ICU management have contributed to improve general outcome. A rational policy of ICU admission triage in these patients is very hard to define, as each decision for ICU admission is a case-by-case decision at patient bedside. The collaboration between hematologists and intensivists is crucial in this context.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Appelbaum FR . Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472–1475.

    Article  CAS  PubMed  Google Scholar 

  2. Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.

    CAS  PubMed  Google Scholar 

  3. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology. Haematologica 2010; 95: 637–643.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617–1624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P et al. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014; 49: 744–750.

    PubMed Central  PubMed  Google Scholar 

  6. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091–2101.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM . Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplant 2006; 37: 119–133.

    Article  CAS  PubMed  Google Scholar 

  8. Azoulay E, Afessa B . The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006; 32: 3–5.

    PubMed  Google Scholar 

  9. Soares M, Salluh JI, Azoulay E . Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: a still pending question. J Crit Care 2010; 25: 37–38.

    PubMed  Google Scholar 

  10. Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810–2818.

    PubMed  Google Scholar 

  11. Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M et al. Managing critically Ill hematology patients: time to think differently. Blood Rev 2015; 29: 359–367.

    PubMed  Google Scholar 

  12. Mokart D, Pastores SM, Darmon M . Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 2014; 40: 1570–1572.

    PubMed  Google Scholar 

  13. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643–649.

    PubMed  Google Scholar 

  14. Rubenfeld GD, Crawford SW . Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 1996; 125: 625–633.

    CAS  PubMed  Google Scholar 

  15. Hill QA . Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev 2010; 24: 17–25.

    PubMed  Google Scholar 

  16. Allareddy V, Roy A, Rampa S, Lee MK, Nalliah RP, Allareddy V et al. Outcomes of stem cell transplant patients with acute respiratory failure requiring mechanical ventilation in the United States. Bone Marrow Transplant 2014; 49: 1278–1286.

    CAS  PubMed  Google Scholar 

  17. Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 2013; 31: 4207–4214.

    PubMed Central  PubMed  Google Scholar 

  18. Benz R, Schanz U, Maggiorini M, Seebach JD, Stussi G . Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant 2014; 49: 62–65.

    CAS  PubMed  Google Scholar 

  19. Boyaci N, Aygencel G, Turkoglu M, Yegin ZA, Acar K, Sucak GT . The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis. Hematology 2014; 19: 338–345.

    PubMed  Google Scholar 

  20. Canet E, Lengline E, Zafrani L, Peraldi MN, Socie G, Azoulay E . Acute kidney injury in critically ill allo-HSCT recipients. Bone Marrow Transplant 2014; 49: 1121–1122.

    CAS  PubMed  Google Scholar 

  21. Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplant 2011; 46: 1186–1191.

    CAS  PubMed  Google Scholar 

  22. Escobar K, Rojas P, Ernst D, Bertin P, Nervi B, Jara V et al. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Catolica de Chile Hospital. Biol Blood Marrow Transplant 2015; 21: 176–179.

    PubMed  Google Scholar 

  23. Galindo-Becerra S, Labastida-Mercado N, Rosales-Padron J, Garcia-Chavez J, Soto-Vega E, Rivadeneyra-Espinoza L et al. Outcome of recipients of hematopoietic stem cell transplants who require intensive care unit support: a single institution experience. Acta Haematol 2015; 134: 119–124.

    PubMed  Google Scholar 

  24. Gilbert C, Vasu TS, Baram M . Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2013; 19: 321–324.

    PubMed  Google Scholar 

  25. Gilli K, Remberger M, Hjelmqvist H, Ringden O, Mattsson J . Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant 2010; 45: 682–688.

    CAS  PubMed  Google Scholar 

  26. Hayani O, Al-Beihany A, Zarychanski R, Chou A, Kharaba A, Baxter A et al. Impact of critical care outreach on hematopoietic stem cell transplant recipients: a cohort study. Bone Marrow Transplant 2011; 46: 1138–1144.

    CAS  PubMed  Google Scholar 

  27. Huynh TN, Weigt SS, Belperio JA, Territo M, Keane MP . Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit. J Transplant 2009; 2009: 917294.

    PubMed Central  PubMed  Google Scholar 

  28. Kew AK, Couban S, Patrick W, Thompson K, White D . Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant 2006; 12: 301–305.

    PubMed  Google Scholar 

  29. Lengline E, Chevret S, Moreau AS, Pene F, Blot F, Bourhis JH et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50: 840–845.

    CAS  PubMed  Google Scholar 

  30. Mokart D, Granata A, Roberto C, Sannini A, Chow-Chine L, Brun JP et al. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care 2015; 30: 1107–1113.

    PubMed  Google Scholar 

  31. Naeem N, Eyzaguirre A, Kern JA, Lazarus HM, Hejal RB, Laughlin MJ et al. Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transplant 2006; 38: 733–738.

    CAS  PubMed  Google Scholar 

  32. Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA . Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 2008; 12: R77.

    PubMed Central  PubMed  Google Scholar 

  33. Solh M, Oommen S, Vogel RI, Shanley R, Majhail NS, Burns LJ . A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2012; 18: 1378–1384.

    PubMed  Google Scholar 

  34. Townsend WM, Holroyd A, Pearce R, Mackinnon S, Naik P, Goldstone AH et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 2013; 161: 578–586.

    PubMed Central  PubMed  Google Scholar 

  35. Yang TM, Wang PN, Kao KC, Huang CC, Tsai YH, Hsieh MJ . Outcome of hematopoietic stem cell recipients who were mechanically ventilated and admitted to intensive care units. J Formos Med Assoc 2007; 106: 295–301.

    PubMed  Google Scholar 

  36. Moreau AS, Seguin A, Lemiale V, Yakoub-Agha I, Girardie P, Robriquet L et al. Survival and prognostic factors of allogeneic hematopoietic stem cell transplant recipients admitted to intensive care unit. Leuk Lymphoma 2014; 55: 1417–1420.

    PubMed  Google Scholar 

  37. Platon L, Amigues L, Ceballos P, Fegueux N, Daubin D, Besnard N et al. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013). Bone Marrow Transplant 2015; 51: 256–261.

    PubMed  Google Scholar 

  38. Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2015; 50: 781–789.

    CAS  PubMed Central  PubMed  Google Scholar 

  39. Legriel S, Marijon H, Darmon M, Lemiale V, Bedos JP, Schlemmer B et al. Central neurological complications in critically ill patients with malignancies. Intensive Care Med 2010; 36: 232–240.

    PubMed  Google Scholar 

  40. Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I et al. Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS ONE 2012; 7: e44534.

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260–2270.

    PubMed  Google Scholar 

  42. Soares M, Salluh JI, Spector N, Rocco JR . Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med 2005; 33: 520–526.

    PubMed  Google Scholar 

  43. Azoulay E, Schlemmer B . Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 2006; 32: 808–822.

    PubMed  Google Scholar 

  44. Mokart D, Saillard C, Sannini A, Chow-Chine L, Brun JP, Faucher M et al. Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hour. Intensive Care Med 2014; 40: 1173–1174.

    PubMed  Google Scholar 

  45. Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P . European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis 2013; 15: 219–232.

    CAS  PubMed  Google Scholar 

  46. Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P . Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013; 56: 258–266.

    PubMed  Google Scholar 

  47. Mariotte E, Schnell D, Scieux C, Agbalika F, Legoff J, Ribaud P et al. Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure. Infection 2011; 39: 225–230.

    CAS  PubMed  Google Scholar 

  48. Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14: 555–563.

    CAS  PubMed  Google Scholar 

  49. Schnell D, Legoff J, Mariotte E, Seguin A, Canet E, Lemiale V et al. Molecular detection of respiratory viruses in immunocopromised ICU patients: incidence and meaning. Respir Med 2012; 106: 1184–1191.

    PubMed  PubMed Central  Google Scholar 

  50. Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C . ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia. Bone Marrow Transplant 2012; 47: 1030–1045.

    CAS  PubMed  Google Scholar 

  51. Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2013; 98: 492–504.

    CAS  PubMed Central  PubMed  Google Scholar 

  52. Marr KA . Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge. Hematology Am Soc Hematol Educ Program 2012; 2012: 265–270.

    PubMed  Google Scholar 

  53. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant 2009; 44: 453–455.

    CAS  PubMed  Google Scholar 

  54. Chi AK, Soubani AO, White AC, Miller KB . An update on pulmonary complications of hematopoietic stem cell transplantation. Chest 2013; 144: 1913–1922.

    PubMed  Google Scholar 

  55. Armenian SH, Chow EJ . Cardiovascular disease in survivors of hematopoietic cell transplantation. Cancer 2014; 120: 469–479.

    PubMed  Google Scholar 

  56. Chao N . How I treat sinusoidal obstruction syndrome. Blood 2014; 123: 4023–4026.

    CAS  PubMed  Google Scholar 

  57. Coplin WM, Cochran MS, Levine SR, Crawford SW . Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 2001; 124: 1043–1051.

    CAS  PubMed  Google Scholar 

  58. Sawinski D . The kidney effects of hematopoietic stem cell transplantation. Adv Chronic Kidney Dis 2014; 21: 96–105.

    PubMed  Google Scholar 

  59. Schlemmer F, Chevret S, Lorillon G, De BC, Peffault de LR, Meignin V et al. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respir Med 2014; 108: 1525–1533.

    PubMed  Google Scholar 

  60. Tichelli A, Rovo A, Gratwohl A . Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematology Am Soc Hematol Educ Program 2008, 125–133.

    Google Scholar 

  61. Tichelli A, Bhatia S, Socie G . Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 2008; 142: 11–26.

    PubMed  Google Scholar 

  62. Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA . Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 2012; 18: 1851–1860.

    PubMed Central  PubMed  Google Scholar 

  63. Wingard JR, Hiemenz JW, Jantz MA . How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation. Blood 2012; 120: 1791–1800.

    CAS  PubMed  Google Scholar 

  64. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 348–371.

    PubMed  Google Scholar 

  65. Faber-Langendoen K, Caplan AL, McGlave PB . Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 1993; 12: 501–507.

    CAS  PubMed  Google Scholar 

  66. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS . Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876–884.

    CAS  PubMed  Google Scholar 

  67. Bach PB, Schrag D, Nierman DM, Horak D, White P Jr, Young JW et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001; 98: 3234–3240.

    CAS  PubMed  Google Scholar 

  68. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697–704.

    CAS  PubMed  Google Scholar 

  69. Schellongowski P, Staudinger T, Kundi M, Laczika K, Locker GJ, Bojic A et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011; 96: 231–237.

    PubMed  Google Scholar 

  70. Groeger JS, White P Jr, Nierman DM, Glassman J, Shi W, Horak D et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 1999; 17: 991–997.

    CAS  PubMed  Google Scholar 

  71. Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB . Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957–1961.

    CAS  PubMed  Google Scholar 

  72. Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002; 287: 345–355.

    PubMed  Google Scholar 

  73. Azoulay E, Lemiale V . Non-invasive mechanical ventilation in hematology patients with hypoxemic acute respiratory failure: a false belief? Bone Marrow Transplant 2012; 47: 469–472.

    CAS  PubMed  Google Scholar 

  74. Saillard C, Mokart D, Lemiale V, Azoulay E . Mechanical ventilation in cancer patients. Minerva Anestesiol 2014; 80: 712–725.

    CAS  PubMed  Google Scholar 

  75. Mokart D, Geay C, Chow-Chine L, Brun JP, Faucher M, Blache JL et al. High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med 2015; 41: 2008–2010.

    PubMed  Google Scholar 

  76. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919.

    CAS  PubMed Central  PubMed  Google Scholar 

  77. Bay JO, Guieze R, Ravinet A, Lemal R, Xhaard A, Bailly S et al. [Major therapeutic advances and new perspectives in onco-hematology]. Bull Cancer 2013; 100: 587–599.

    PubMed  Google Scholar 

  78. Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica 2013; 98: 1836–1847.

    PubMed Central  PubMed  Google Scholar 

  79. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011; 52: e56–e93.

    PubMed  Google Scholar 

  80. Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 update. Bone Marrow Transplant 2011; 46: 709–718.

    CAS  PubMed  Google Scholar 

  81. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58: 309–318.

    PubMed  Google Scholar 

  82. Fuchs EJ . HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transplant 2015; 50 (Suppl 2): S31–S36.

    CAS  PubMed Central  PubMed  Google Scholar 

  83. Reisner Y, Aversa F, Martelli MF . Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transplant 2015; 50 (Suppl 2): S1–S5.

    PubMed  Google Scholar 

  84. Bacigalupo A . Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant 2004; 33: 691–696.

    CAS  PubMed  Google Scholar 

  85. Blaise D, Castagna L . Do different conditioning regimens really make a difference? Hematology Am Soc Hematol Educ Program 2012; 2012: 237–245.

    PubMed  Google Scholar 

  86. Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C et al. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev 2014; 4: CD010189.

    Google Scholar 

  87. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    PubMed  Google Scholar 

  88. Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100: 4337–4343.

    CAS  PubMed  Google Scholar 

  89. Mokart D, Lambert J, Schnell D, Fouche L, Rabbat A, Kouatchet A et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013; 54: 1724–1729.

    PubMed  Google Scholar 

  90. Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36: 100–107.

    PubMed  Google Scholar 

  91. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038–1046.

    PubMed  Google Scholar 

  92. Lengline E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012; 53: 1352–1359.

    PubMed  Google Scholar 

  93. de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A et al. Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock 2013; 39: 250–254.

    PubMed  Google Scholar 

  94. Song JU, Suh GY, Park HY, Lim SY, Han SG, Kang YR et al. Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med 2012; 38: 1505–1513.

    PubMed  Google Scholar 

  95. Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, Schlemmer B et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008; 32: 748–754.

    CAS  PubMed  Google Scholar 

  96. Thiery G, Azoulay E, Darmon M, Ciroldi M, De MS, Levy V et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406–4413.

    PubMed  Google Scholar 

  97. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165–228.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327–336.

    PubMed  Google Scholar 

  99. Lemiale V, Resche-Rigon M, Azoulay E . Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial. Trials 2014; 15: 372.

    PubMed Central  PubMed  Google Scholar 

  100. Lemiale V, Mokart D, Resche-Rigon M, Pene F, Mayaux J, Faucher E et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 2015; 314: 1711–1719.

    CAS  PubMed  Google Scholar 

  101. Lemiale V, Resche-Rigon M, Mokart D, Pene F, Rabbat A, Kouatchet A et al. Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en reanimation onco-hematologique (Grrr-OH) study. Ann Intensive Care 2015; 5: 28.

    PubMed Central  PubMed  Google Scholar 

  102. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481–487.

    CAS  PubMed  Google Scholar 

  103. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372: 2185–2196.

    CAS  PubMed  Google Scholar 

  104. Lemiale V, Mokart D, Mayaux J, Lambert J, Rabbat A, Demoule A et al. The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Crit Care 2015; 19: 380.

    PubMed Central  PubMed  Google Scholar 

  105. Vrhovac R, Labopin M, Ciceri F, Finke J, Holler E, Tischer J et al. Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. Bone Marrow Transplant 2015; 51: 186–193.

    PubMed  Google Scholar 

  106. August DA, Huhmann MB . ASPEN clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 2009; 33: 472–500.

    PubMed  Google Scholar 

  107. Bassim CW, Fassil H, Dobbin M, Steinberg SM, Baird K, Cole K et al. Malnutrition in patients with chronic GVHD. Bone Marrow Transplant 2014; 49: 1300–1306.

    CAS  PubMed Central  PubMed  Google Scholar 

  108. Fuji S, Einsele H, Savani BN, Kapp M . Systematic nutritional support in allogeneic hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2015; 21: 1707–1713.

    PubMed  Google Scholar 

  109. Seguy D, Duhamel A, Rejeb MB, Gomez E, Buhl ND, Bruno B et al. Better outcome of patients undergoing enteral tube feeding after myeloablative conditioning for allogeneic stem cell transplantation. Transplantation 2012; 94: 287–294.

    CAS  PubMed  Google Scholar 

  110. Zatarain L, Savani BN . The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation. Cell Immunol 2012; 276: 6–9.

    CAS  PubMed  Google Scholar 

  111. Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599–608.

    PubMed  Google Scholar 

  112. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138–151.

    PubMed  Google Scholar 

  113. Blaise D, Devillier R, Lecoroller-Sorriano AG, Boher JM, Boyer-Chammard A, Tabrizi R et al. Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial. Haematologica 2015; 100: 269–274.

    PubMed Central  PubMed  Google Scholar 

  114. Oeyen SG, Benoit DD, Annemans L, Depuydt PO, Van Belle SJ, Troisi RI et al. Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study. Intensive Care Med 2013; 39: 889–898.

    CAS  PubMed  Google Scholar 

  115. Roze des Ordons AL, Chan K, Mirza I, Townsend DR, Bagshaw SM . Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study. BMC Cancer 2010; 10: 516.

    PubMed Central  PubMed  Google Scholar 

  116. Azoulay E, Chaize M, Kentish-Barnes N . Involvement of ICU families in decisions: fine-tuning the partnership. Ann Intensive Care 2014; 4: 37.

    PubMed Central  PubMed  Google Scholar 

  117. Kentish-Barnes N, McAdam JL, Kouki S, Cohen-Solal Z, Chaize M, Galon M et al. Research participation for bereaved family members: experience and insights from a qualitative study. Crit Care Med 2015; 43: 1839–1845.

    PubMed  Google Scholar 

  118. Afessa B, Azoulay E . Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 2010; 26: 133–150.

    CAS  PubMed  Google Scholar 

  119. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519–525.

    CAS  PubMed  Google Scholar 

  120. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E . The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808–814.

    PubMed  Google Scholar 

  121. Azoulay E, Kouatchet A, Jaber S, Meziani F, Papazian L, Brochard L et al. Non-invasive ventilation for end-of-life oncology patients. Lancet Oncol 2013; 14: e200–e201.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Institut Paoli Calmettes, Marseille, France

    C Saillard & D Blaise

  2. Department of Anesthesiology and Critical Care, Polyvalent Intensive Care Unit, Institut Paoli Calmettes, Marseille, France

    D Mokart

Authors
  1. C Saillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Blaise
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Mokart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Mokart.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saillard, C., Blaise, D. & Mokart, D. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 51, 1050–1061 (2016). https://doi.org/10.1038/bmt.2016.72

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.72

This article is cited by

Search

Advanced search

Quick links